Document is current
Any future updates will be listed below
-
Authors
Ornello, Raffaele
Casalena, Alfonsina
Frattale, Ilaria
Caponnetto, Valeria
Gabriele, Amleto
Affaitati, Giannapia
Giamberardino, Maria Adele
Assetta, Maurizio
Maddestra, Maurizio
Marzoli, Fabio
Viola, Stefano
Cerone, Davide
Marini, Carmine
Pistoia, Francesca
Sacco, Simona https://orcid.org/0000-0003-0651-1939
-
Funding
Funding for this research was provided by:
Novartis Pharma
- License Information
-
More Information
Article History
Received: 19 July 2020
Accepted: 11 August 2020
First Online: 15 August 2020
Ethics approval and consent to participate
: The study was approved by the Internal Review Board of the University of L’Aquila (Italy) and patients gave written informed consent according to the Declaration of Helsinki.
: Not applicable.
: RO has received sponsorship to attend meetings from Novartis and Teva; SS had a financial relationship (lecturer or member of advisory board) with Abbott, Allergan, Novartis, Teva, and Eli Lilly; GA has received funds for congress participation from Innovet Italia Srl, Epitech Group and Lusofarmaco; MAG received funds for congress participation from IBSA; AC, IF, AG, MA, MM, FM, SV, DC, CM, and FP declare no competing interests.
